Galapagos NV header image

Galapagos NV

GLPG

Equity

ISIN null / Valor 3542077

NASDAQ (2026-05-01)

USD 28.00+0.61%

Galapagos NV
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Galapagos NV is a biotechnology firm specializing in oncology and the development of CAR-T therapies and biologics. In 2022, the company expanded its capabilities by acquiring CellPoint and AboundBio, thereby establishing comprehensive end-to-end CAR-T development processes. These acquisitions have enabled Galapagos to implement a decentralized T-cell manufacturing platform and utilize advanced fully human antibody technologies, positioning the company to innovate and advance next-generation CAR-T treatments and biologic therapies within the medical field.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

4.56%1Y

-29.8%3Y

-64.0%5Y

Performance

31.1%1Y

29.4%3Y

33.0%5Y

Volatility

1845 M

Market cap (USD)

107,777

Daily traded volume (Shares)

27.4 / 26.99

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc Valor: 24511852

Annual Return

-50%0%+50%

Risk level

110

-0.36%USD 21.88

Schrodinger Inc

Schrodinger Inc Valor: 51947209

Annual Return

-50%0%+50%

Risk level

110

3.60%USD 12.39

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

0.35%USD 2.84

Outset Medical Inc

Outset Medical Inc Valor: 56717137

Annual Return

-50%0%+50%

Risk level

110

2.11%USD 4.36

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

-3.59%USD 68.56

Protagonist Therapeutics Inc

Protagonist Therapeutics Inc Valor: 33278818

Annual Return

-50%0%+50%

Risk level

110

-0.61%USD 98.37

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

0.94%USD 2.15

Summit Therapeutics Inc

Summit Therapeutics Inc Valor: 56903013

Annual Return

-50%0%+50%

Risk level

110

-24.91%USD 16.11

Glaukos Corp

Glaukos Corp Valor: 28262610

Annual Return

-50%0%+50%

Risk level

110

-2.40%USD 140.22

Hims & Hers Health Inc

Hims & Hers Health Inc Valor: 59397181

Annual Return

-50%0%+50%

Risk level

110

0.88%USD 27.41

SIX

FactSet

Clearbit

Logos provided by Clearbit